Familial B-cell Lymphoproliferative Disorders
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Clinical Trials Related to Chronic Lymphocytic Leukemia
Related studies linked through entity extraction aliases.
Tafasitamab and Zanubrutinib for the Treatment of Patients With Newly Diagnosed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, TaZA CLL Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Metabolically Fit CD19 CAR T-cell Therapy With CD34 Selection in Patients With CD19+ Relapsed/Refractory NHL, CLL/SLL
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Dose Escalation/Dose Expansion Study of PRGN-3007 UltraCAR-T Cells in Patients With Advanced Hematologic and Solid Tumor Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Ibrutinib for the Treatment of AIHA in Patients With CLL/SLL or CLL-like MBL
- Status
- RECRUITING
- Phase
- PHASE2
Pirtobrutinib and Venetoclax With MRD Detection for Previously Untreated Chronic Lymphocytic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia
- Status
- SUSPENDED
- Phase
- PHASE2
Implanted Loop Recorders for Detection and Management of Arrhythmia With Bruton Tyrosine Kinase Inhibitors
- Status
- RECRUITING
- Phase
- NA
A Study of Nemtabrutinib vs Chemoimmunotherapy for Participants With Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Without TP53 Aberrations (MK-1026-008, BELLWAVE-008)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
Bringing Optimised COVID-19 Vaccine Schedules To ImmunoCompromised Populations (BOOST-IC): an Adaptive Randomised Controlled Clinical Trial
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study to Assess Change in Patient Experience in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Venetoclax Tablets + Intravenous Rituximab or Bruton's Tyrosine Kinase Inhibitors Tablets in the United Kingdom
- Status
- COMPLETED
- Phase
- N/A
Study of SGR-1505 in Mature B-Cell Neoplasms
- Status
- RECRUITING
- Phase
- PHASE1
Cardiotoxicities in Patients Receiving BTKi
- Status
- WITHDRAWN
- Phase
- N/A
A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)
- Status
- RECRUITING
- Phase
- PHASE1
Front-line VenObi Combination Followed by Ven or VenZan Combination in Patients With Residual Disease: a MRD Tailored Treatment for Young Patients With High-risk CLL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Passive Antibodies Against COVID-19 With EVUSHELD in Vaccine Non-responsive CLL
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
National Acalabrutinib Observational Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A